Jacobs Levy Equity Management’s aTyr Pharma ATYR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-2,029
| Closed | -$75K | – | 1116 |
|
|
2018
Q1 | $75K | Sell |
2,029
-607
| -23% | -$22.4K | ﹤0.01% | 974 |
|
|
2017
Q4 | $129K | Sell |
2,636
-758
| -22% | -$37.1K | ﹤0.01% | 943 |
|
|
2017
Q3 | $240K | Buy |
+3,394
| New | +$240K | ﹤0.01% | 827 |
|
|
2017
Q1 | – | Sell |
-6,791
| Closed | -$204K | – | 1010 |
|
|
2016
Q4 | $204K | Sell |
6,791
-3,135
| -32% | -$94.2K | ﹤0.01% | 831 |
|
|
2016
Q3 | $442K | Buy |
9,926
+6,330
| +176% | +$282K | 0.01% | 740 |
|
|
2016
Q2 | $140K | Buy |
3,596
+596
| +20% | +$23.2K | ﹤0.01% | 1060 |
|
|
2016
Q1 | $165K | Buy |
+3,000
| New | +$165K | ﹤0.01% | 993 |
|